ISOPS 2024

Poster Session
Programme

PHARMACEUTICAL CHEMISTRY
P001SYNTHESIS AND ELUCIDATION OF SOME NEW CARBAMATE COMPOUNDS DESIGNED BASED ON THE PHARMACOPHORE GROUP OF HDAC INHIBITORS
P002BIOLOGICAL EVALUATION OF ALKYLSULFONYL 1H-BENZIMIDAZOLE DERIVATIVES AS POTENTIAL ANTIBACTERIAL AND ANTIFUNGAL AGENTS
P003STUDIES ON SYNTHESIS OF NOVEL BENZYL THIAZOLYL CARBAMATE DERIVATIVE COMPOUNDS AND THEIR ACTIVITIES HDAC ENZYME INHIBITOR
P004STUDIES ON THE SYNTHESIS OF NOVEL IMIDAZO PYRIDINYL CARBAMATES AND THEIR HDAC ENZYME INHIBITOR ACTIVITIES
P005DESIGN, SYNTHESIS, MOLECULAR DOCKING AND ADME STUDIES OF NOVEL THIAZOLIDINEDIONE DERIVATIVES AS TUBULIN POLYMERASE INHIBITORS
P006DESIGN, SYNTHESIS, MOLECULAR DOCKING AND ADME STUDIES OF NOVEL THIAZOLIDINEDIONE DERIVATIVES AS CDK4/6 INHIBITORS
P007NOVEL (4-CHLORO-2-((1-PHENYL-1H-TETRAZOL-5-YL)THIO)THIAZOL-5-YL)METHYL (2-AMINOPHENYL)CARBAMATES AS HDAC ENZYME INHIBITORS
P008IN SILICO STUDY: DRUGLIKENESS PROPERTIES OF ACETYL-L-CARNITINE ANALOGUES
P009SYNTHESIS AND ANTICANCER ACTIVITY STUDIES OF NOVEL 1,3,4- THIADIAZOLE DERIVATIVES
P010DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF AZOLE-HYDRAZONE DERIVATIVES AS POTENTIAL TYROSINASE INHIBITORS
P011SYNTHESIS, CHARACTERIZATION AND STRUCTURE ELUCIDATION OF SOME NEW ADENINE-THIOUREA DERIVATIVES BY CONVENTIONAL AND MICROWAVE SYNTHESIS METHODS
P012EVALUATION OF THE ANTIMICROBIAL ACTIVITY OF NEW CHALCONE DERIVATIVES
P013SYNTHESIS OF A GROUP OF BENZIMIDAZOLE DERIVATIVES AND IN VITRO INVESTIGATION OF THEIR ΑLPHA-GLUCOSIDASE INHIBITORY ACTIVITY
P014EVALUATION OF CHOLINESTERASE INHIBITORY ACTIVITIES OF 2-AMINOPYRIMIDINE-PHENYLUREA DERIVATIVES AND MOLECULAR DOCKING STUDIES
P015INVESTIGATION OF N-(4-PYRIDINYLAMINOMETHYL)-PHTHALIMIDE AS MTDL FOR THE TREATMENT OF AD AND T2DM
P016INVESTIGATION OF POTENTIAL ANTIOXIDANT AND CYTOTOXIC ACTIVITIES OF NOVEL HYDROXYPYRIDINONE DERIVATIVES
P017SYNTHESIS AND CALCIUM CHANNEL BLOCKING ACTIVITY OF TETRAHYDROCHROMENE-3-CARBONITRILE DERIVATIVES
P018EVALUATION OF SEVERAL PYRROLOPYRIMIDINE-PHENYLUREA COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
P019SYNTHESIS OF SOME N’-BENZYLIDENE-1H-BENZIMIDAZOLE-5-CARBOHYDRAZIDE DERIVATIVES
P020SYNTHESIS OF NEW ETHYL 2-((5-SUBSTITUTEDBENZYLIDENE-4-OXO-4,5-DIHYDROTHIAZOL-2-YL)AMINO)THIAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND EVALUATION OF THEIR ANTICANCER ACTIVITIES
P021NEW SUBSTITUTED PIPERAZINE LINKED INDOLIN-2-ONES AS POTENTIAL VEGFR-2 INHIBITORS
P022SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL 1,4-DIHYDROPYRIMIDINE DERIVATIVES AS POTENTIAL CALCIUM CHANNEL BLOCKERS
P023SYNTHESIS, CHARACTERIZATION, AND CYTOTOXIC ACTIVITY OF PLATINUM(II) COMPLEXES WITH 2 AND/OR 5-SUBSTITUTED BENZIMIDAZOLE AS CARRIER LIGAND
P024SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME N-(HETEROARYLAMINOMETHYL)-BENZOXAZOLONE DERIVATIVES
P025SYNTHESIS AND INVESTIGATION TYROSINASE INHIBITOR ACTIVITIES OF NOVEL COMPOUNDS CARRYING 4-(4-FLUOROBENZYL)PIPERAZINE FRAGMENT
P026DESIGN AND SYNTHESIS OF SOME NEW CHROMONE DERIVATIVES AS ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS
P027DETERMINATION OF SOME INDOLE DERIVATIVES AS ACHE AND BUCHE INHIBITORS FOR ALZHEIMER’S DISEASE BY MOLECULAR DOCKING STUDIES
P028SYNTHESIS AND BIOLOGICAL ACTIVITY STUDIES ON NOVEL THIOUREA DERIVATIVES
P029IN SILICO STUDIES OF SOME NOVEL METHYL BENZOXAZOLE-6-CARBOXYLATE DERIVATIVES AS hTOPO IIα INHIBITORS
P030SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF PLATINUM(II) COMPLEXES WITH AZOLE DERIVATIVES AS CARRIER LIGANDS
P031DETERMINATION OF ANTIOXIDANT ACTIVITY OF 2-MERCAPTOSUBSTITUTED 1H-BENZO[D]IMIDAZOLE COMPOUNDS
ANALYTICAL CHEMISTRY
P032VOLTAMMETRIC DETERMINATION OF TERAZOSIN HCL FROM PHARMACEUTICAL DOSAGE FORMS USING POLY(ALLURA RED AC) MODIFIED GLASSY CARBON ELECTRODE
P033DEVELOPMENT OF A NEW POLYMER-BASED ELECTROCHEMICAL SENSOR FOR ANALYSIS OF MELATONIN AND ITS DETERMINATION FROM PHARMACEUTICALS AND BIOLOGICAL SAMPLES
P034SPECTROSCOPIC AND IN SILICO APPROACHES ON THE INTERACTION BETWEEN ORPHAN DRUG NITISINONE AND BOVINE SERUM ALBUMIN
P035THE INTERACTION STUDY OF ABIRATERONE ACETATE AND DNA USING PHENYLALANINE-COATED COPPER NANOCLUSTERS AS A FLUORESCENT PROBE
P036INVESTIGATION TWO ACRIDONE DERIVATIVES DRUGS INTERACTION WITH DNA BY SPECTROSCOPY METHODS
P037DEVELOPMENT OF A STABILITY-INDICATING RP-HPLC METHOD FOR THE DETERMINATION OF BARICITINIB IN BULK
P038FDG OPTIMIZATION
P039THE IMPACT OF MOTILIN’S SURFACE ADSORPTION BEHAVIOR ON ANALYTICAL SENSITIVITY
P040CONSTRUCTION OF TiO2-CNF INCORPORATED BIMETALLIC Au-PdNPs BASED APTASENSOR FOR HIGHLY SENSITIVE FOOD ALLERGEN DETECTION IN REAL FOOD SAMPLES
P041PAPER-BASED DNA EXTRACTION METHOD FOR MOLECULAR DETECTION OF PATHOGEN BACTERIA
P042DEVELOPMENT OF HPLC METHOD FOR DETERMINATION OF TEICOPLANIN FROM POLYMERIC BASED DRUG DELIVERY SYSTEM
P043QUANTITATIVE ANALYSIS OF MONOMER RELEASE FROM PEDIATRIC RESTORATIVE MATERIAL DUST USING HPLC-UV
P044EVALUATION OF TICAGRELOR CRUSHED TABLET SUSPENSION WITH NASOGASTRIC TUBE APPLICATION BY IN VITRO ANALYSIS
P045SENSITIVE LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR THE DETERMINATION OF ANTIDEPRESSANT DRUG VORTIOXETINE IN RAT BRAIN TISSUE
P046DEVELOPMENT OF A MOLECULARLY IMPRINTED POLYMER-BASED ELECTROCHEMICAL SENSOR FOR SELECTIVE AND SENSITIVE DETERMINATION OF LINCOMYCIN
P047THERAPEUTIC DRUG MONITORING OF THE ANTIPSYCHOTIC DRUG IN PLASMA BY GC-MS
P048DESIGNING A GOLD NANOCLUSTERS-SUPPORTED MOLECULARLY IMPRINTED POLYMER-BASED ELECTROCHEMICAL SENSOR FOR SPECIFIC RECOGNITION AND DETERMINATION OF SCOPOLAMINE
P049DEVELOPMENT AND VALIDATION OF A RAPID RESOLUTION LIQUID CHROMATOGRAPHY-DIODE ARRAY DETECTOR METHOD FOR THE DETERMINATION of DEXKETOPROFEN AND THIOCOLCHICOSIDE
P050THERAPEUTIC DRUG MONITORING OF THE FREE AND TOTAL CONCENTRATION OF PALBOCICLIB IN PLASMA BY LC-MS/MS
P051DETERMINATION OF STRESS CONDITIONS OF NIRMATRELVIR AND RITONAVIR UNDER FORCED DEGRADATION STUDY
P052UV-VIS SPECTROSCOPY METHOD ALLIED WITH CHEMOMETRICS FOR SIMULTANEOUS ANALYSIS OF DEXKETOPROFEN TROMETAMOL AND THIOCOLCHICOSIDE IN COMMERCIAL TABLETS
P053INFRARED SPECTROSCOPY COMBINED WITH CHEMOMETRICS FOR SIMULTENOUS RECOGNITION OF DEXKETOPROFEN TROMETAMOL AND THIOCOLCHICOSIDE IN COMMERCIAL TABLETS
P054SIMPLE SPECTROPHOTOMETRIC DETERMINATION OF LIPID MODIFYING AGENTS IN A BINARY MIXTURE USING MATRIX RESOLUTION METHOD
P055METHOD DEVELOPMENT BY CAPILLARY ELECTROPHORESIS FOR LORNOXICAM DETERMINATION IN PHARMACEUTICAL TABLETS
P056STABILITY-INDCATIING ICP-MS METHOD DEVELOPMENT FOR THE DETERMINATION OF LEAD IN CALCIUM
P057EVALUATION OF APIXABAN CRUSHED TABLET SUSPENSION WITH NASOGASTRIC TUBE APPLICATION BY IN VITRO ANALYSIS
P058GREEN SYNTHESIS OF SILVER AND ZINC NANOPARTICLES USING PROPOLIS EXTRACTS OBTAINED FROM GİRESUN REGION AND THEIR ANTIMICROBIAL, ANTIBIOFILM AND ANTI-QUARUM SENSING ACTIVITIES
P059APPLICATION OF BOX-BEHNKEN DESIGN (BBD) ON THE HPLC METHOD DEVELOPMENT FOR ANALYSIS OF ASUNAPREVIR IN PHARMACEUTICAL FORMULATIONS
PHARMACEUTICAL MICROBIOLOGY
P060ANALYSIS OF ANTIBIOTIC USAGE AT SHOGAT “PROF. DR. D. STAMATOV,” VARNA, BULGARIA, FROM 2017 TO 2023
P061AN ASSESSMENT OF CEFIDEROCOL’S SYNERGISTIC EFFECTS WITH, COLISTIN, TIGECYCLINE, LEVOFLOXACIN, CEFTAZIDIME/AVIBACTAM, AND TRIMETHOPRIM/SULFAMETHOXAZOLE AGAINST MULTI-DRUG RESISTANT STENOTROPHOMONAS MALTOPHILIA
PHARMACEUTICAL TECHNOLOGY
P062DEVELOPMENT AND CHARACTERIZATION OF TAMOXIFEN CITRATE LOADED ɣ-CYCLODEXTRIN METAL ORGANIC FRAMEWORKS
P063DEVELOPMENT AND CHARACTERIZATION OF ACTIVE TARGETED GOLD NANOPARTICLES FOR TUBERCULOSIS TREATMENT
P064IN VITRO EVALUATION OF EMULGEL AND NANOEMULGEL FORMULATIONS OF DICLOFENAC POTASSIUM FOR TOPICAL APPLICATION
P065DETERMINATION OF CRITICAL MICELLE CONCENTRATION OF POLYMER MIXTURES BY DONOR-ACCEPTOR INTERACTION WITH IODINE
P066PREPARATION AND IN VITRO EVALUATION OF OPHTALMIC MICROEMULSION FORMULATIONS OF MOXIFLOXACIN HYDROCHLORIDE
P067ENHANCING THE AQUEOUS SOLUBILITY OF LORNOXICAM VIA CYCLODEXTRIN COMPLEXATION
P068INVESTIGATING THE IMPACT OF DISSOLUTION METHOD ON THE DISSOLUTION PROFILE OF LORNOXICAM-LOADED TABLETS FABRICATED VIA FDM-3DP TECHNOLOGY
P069THE EFFECT OF FREEZE-DRYING ON THE CHARACTERISTICS OF RIBOFLAVIN-LOADED NANOPARTICLES FOR THE PHOTODYNAMIC THERAPY
P070STUDIES ON THE FORMULATION OF TWO DİFFERENT MODEL BIOLOGICALLY ACTIVE SUBSTANCES
P071DESIGN OF EXPERIMENT APPROACH TO MODELING THE EFFECTS OF FORMULATION ON DRUG RELEASE FROM LIPID NANOCAPSULES
P072PREPARATION OF KHELLIN-CONTAINING NANOFIBERS VIA ELECTROSPINNING FOR THE TREATMENT OF VITILIGO
P073FORMULATION STUDIES OF LETROZOLE INCORPORATED KOLLIDON® SR POLYMERIC PARTICLES
P074PREPARATION AND CHARACTERIZATION OF FAST DISSOLVING TRIAMCINOLONE ACETONIDE ORAL FILM FOR RECURRENT APHTHOUS STOMATITIS
P075DEVELOPMENT AND CHARACTERIZATION OF POSACONAZOLE LOADED SELF NANOEMULSIFYING FORMULATION
P076DEVELOPMENT OF MAGNETIC METAL ORGANIC FRAMEWORKS AS DRUG DELIVERY SYSTEMS
P077PREPARATION AND EVALUATION OF GELATIN/ALGINATE-BASED INKS FOR 3D PRINTING OF BONE SCAFFOLDS
P078DEVELOPMENT AND IN VITRO EVALUATION OF SILK PROTEIN AND SPIRULINA MICROPARTICLES LOADED HYDROGEL FORMULATIONS
P079DEVELOPMENT OF AN OCULAR IN-SITU GEL FORMULATION CONTAINING INDOMETHACIN
P080DEVELOPMENT OF CURCUMIN LOADED AQUASOMES BY USING CENTRAL COMPOSITE DESIGN
P081PREPARATION OF GARLIC AND LAVENDER OIL-CONTAINING NANOFIBERS VIA ELECTROSPINNING FOR THE TREATMENT OF ALOPECIA AREATA
P082EVALUATION OF CHITOSAN-COATED NANOLIPOSOMES CONTAINING VARDENAFIL FOR PULMONARY ARTERIAL HYPERTENSION
P083IN-SITU GEL FORMULATION WITH ANTI-INFLAMMATORY EFFECT FOR PREVENTING ALVEOLAR OSTEITIS AND ORAL WOUNDS
P084ENHANCED OCULAR DELIVERY OF VORICONAZOLE UTILIZING POLYMERIC NANOPARTICLES: A PROMISING STRATEGY FOR TREATING FUNGAL KERATITIS
P085PREPARATION AND CHARACTERIZATION OF OLANZAPINE LOADED NANOSPONGES
P086DEVELOPMENT OF A POLYESTER BASED THERMO-RESPONSIVE HYDROGEL FORMULATION FOR DICLOFENAC SODIUM DELIVERY
P087STRAT-M®- TRANSDERMAL DIFFUSION TEST MEMBRANE: IN-VITRO PERMEATION STUDIES WITH DIFFERENT PENETRATION ENHANCERS
P088DEVELOPMENT OF DUAL-MEDIATED LIPOSOMAL SYSTEMS
P089ENCAPSULATION OF PROBIOTIC BACTERIA USING MICROFLUIDIC CHIP SYSTEM FOR ULCERATIVE COLITIS TREATMENT
P090DEVELOPMENT OF A THERAPEUTIC DNA APTAMER THAT TARGETS PERIPLASMIC LIPID A-BINDING PROTEIN (LPTA) IN LPT ABC TRANSPORTER SYSTEM
P091DEVELOPMENT OF PRONIOSOMAL DRY POWDER INHALER FORMULATIONS USING DIFFERENT METHODS
P092CHITOSAN-POLYVINIL ALCOHOL BASED ORAL HYDROGEL FORMULATIONS FOR COLON TARGETING
P093ANTIBIOTIC LOADED THERMOSENSITIVE HYDROGEL FORMULATION FOR OTITIS MEDIA TREATMENT
P094THE EFFECT OF COMBINED POLYMER USAGE AND NUMBER OF LAYERS ON THE CHARACTERIZATION OF 3D PRINTED METRONIDAZOLE-LOADED PERIODONTAL FILMS
P095COMPARATIVE EVALUATION OF THE ANTIFUNGAL ACTIVITY OF TOPICAL GELS CONTAINING TEA TREE, THYME AND CLOVE ESSENTIAL OILS
P096DESIGN AND IN VITRO CHARACTERIZATION OF NIOSOMES LOADED WITH VITAMIN C
P097INVESTIGATING THE IMPACT OF CROSS-LINKER TYPE ON PARTICLE SIZE AND ZETA POTENTIAL OF ALBUMIN NANOPARTICLES
P098STIMULI-RESPONSIVE FIBERS FOR SKIN TISSUE ENGINEERING
P099CENTRIFUGAL SPUN MICROFIBERS FOR THE TREATMENT OF SKIN CHRONIC WOUNDS
P100ANTIBACTERIAL POLYMERIC NANOPARTICLES EMBEDDED INTO ZEIN SURFACE COATINGS AS A PROMISING TOOL FOR IMPROVING IMPLANT BIOACTIVITY
P101INORGANIC NANOPARTICLES-DOPED NANOFIBROUS SCAFFOLD FOR SKIN REGENERATION
P102PREPARATION AND IN VITRO EVALUATION OF POLYMERIC NANOPARTICLE FORMULATIONS CONTAINING CARVEDILOL
P103PREPARATION AND IN VITRO EVALUATION OF NORFLOXACIN-LOADED PLGA NANOPARTICLES FOR OCULAR APPLICATION
PHARMACEUTICAL TOXICOLOGY
P104CYTOKINE GENETIC VARIANTS LINKED TO THE DEVELOPMENT AND COMPLICATION OF TYPE 2 DIABETES AMONG A GROUP OF TURKISH PEOPLE
P105ASSESSMENT OF THE IMPACT OF POTASSIUM CYANIDE EXPOSURE AND THYROID HOMEOSTASIS ON JEWELRY WORKERS
P106INVESTIGATION OF THE DNA DAMAGE-INDUCING PROPERTIES OF BPA, BPS, AND BPZ ON MCF-7 CELL LINE
P107INVESTIGATING THE AMELIORATIVE EFFECT OF SITAGLIPTIN AGAINST tert-BUTYL HYDROPEROXIDE INDUCED TOXICITY IN HEPG2 CELLS
P108MICROPLASTICS AND THE EMERGING CONCERNS ABOUT FOOD SAFETY: A BIBLIOMETRIC PERSPECTIVE
P109DNA REPAIR CAPACITY IN RESPONSE TO HYDROGEN PEROXIDE-INDUCED OXIDATIVE DNA DAMAGE IN 3T3 CELL LINE
P110THE SURVIVAL RATE OF ISOLATED LYMPHOCYTES UNDER DIFFERENT STORAGE CONDITIONS
P111COMPARATIVE HEAVY METAL ANALYSIS OF TAR PHASES ISOLATED FROM THE MAINSTREAM SMOKES OF CONVENTIONAL CIGARETTES AND HEATED TOBACCO PRODUCTS
P112INVESTIGATION OF THE HEPATOTOXIC EFFECTS OF SOME HERBAL PRODUCTS BY IN VİTRO METHOD
P113EVALUATION OF THE HEPATOTOXICITY OF HYDROXYCHLOROQUINE SULFATE IN RATS
P114INVESTIGATION OF CYTOTOXICITY OF 2,4-D AND GLYPHOSATE BASED HERBICIDE USING ONCORHYNCHUS MYKISS (RAINBOW TROUT) LIVER CELLS (RTL-W1)
P115PREDICTING ENDOCRINE DISTRUPTING AND DEVELOPMENTAL EFFECTS OF SYNTHETIC CATHINONES VIA IN SILICO EVALUATION
P116A PRELIMINARY STUDY OF THE EFFECT OF CITRUS SPECIES ON HEPATIC CYP1A1 ACTIVITY
HISTORY OF PHARMACY AND MANAGEMENT
P117PHARMACEUTICAL INDUSTRY AND SUSTAINABLE DEVELOPMENT GOALS
P118AN EVALUATION OF THE PHARMACIST COOPERATIVES WEBSITES
P119HEALTH IN DIGITAL MEDIA: AN EVALUATION OF HEALTH-RELATED PODCASTS
P120AN EVALUATION OF PHARMACY EDUCATION IN TERMS OF PLANETARY HEALTH
P121PROMOTING ETHICAL LEADERSHIP IN COMMUNITY PHARMACIES
P122COMMUNITY PHARMACISTS AS KEY PLAYERS IN HANDLING NEGATIVE OUTCOMES
P123DESIGNING A RESEARCH STUDY ON SIGNAL MANAGEMENT FOR QUALITY ASSURANCE WITHIN A MEDICINAL PRODUCTS REGULATORY SCIENCES SCENARIO
PHARMACOGNOSY
P124PHARMACOPOEIA ANALYSIS OF SOME PLANT MATERIALS SOLD AS CALENDULA (CALENDULA OFFICINALIS L.) IN THE MARKET
P125INVESTIGATION OF CHEMICAL COMPOSITION AND ANTICANCER ACTIVITY OF STACHYS OFFICINALIS (L.) TREVISAN SUBSP. BALCANICA (P.W. BALL) R. BHATTACHARJEE ESSENTIAL OIL
P126PHARMACOPOEIAL ANALYSIS OF SOME PLANT MATERIALS SOLD IN THE MARKET AS FLAXSEED (LINUM USITATISSIMUM L.)
P127INVESTIGATION OF ANTIBACTERIAL ACTIVITY OF TERTIARY ALKALOID RICH EXTRACT AND ZINC NANOPARTICLES SYNTHESIZED FROM MANDRAGORA OFFICINALIS L
P128CHEMICAL COMPOSITION OF SCROPHULARIA XANTHOGLOSSA BOISS. ESSENTIAL OIL
P129ANTIMICROBIAL, ANTIBIOFILM, AND ANTI-QUORUM SENSING (ANTI-QS) ACTIVITIES OF SCUTELLARİA YİLDİRİMLİİ M. ÇİÇEK & A.E. YAPRAK
P130ESSENTIAL OIL COMPOSITION OF THE AERIAL PART OF ANKARA ENDEMIC PRANGOS DENTICULATA FISCH. ET MEY
P131PHYTOCHEMICAL EVALUATION OF TOMATO PASTE FACTORY BY-PRODUCTS: “AYAŞ” AND “EGG TOMATO” SEED OILS
P132PHYTOCHEMICAL PROFILING AND ANTIOXIDANT EVALUATION OF NEPETA TRANSCAUCASICA
P133STUDIES ON INSECTICIDAL EFFECT AND PHYTOCHEMICAL PROPERTIES OF CYANUS DEPRESSUS (M. BIEB.) SOJÁK
P134EVALUATION OF CYTOTOXIC POTENTIAL OF ENDEMIC DIANTHUS GOEKAYI ON MCF-7 AND MDA-MB-231 CELL LINES
P135PHARMACOPEIAL ANALYSIS OF EUCALYPTUS ESSENTIAL OILS
P136MORPHOLOGICAL AND ANATOMICAL STUDIES ON HERBAL MATERIALS SOLD IN THE MARKET AS MALLOW (MALVA SYLVESTRIS L.)
P137PHARMACOGNOSTICAL STUDIES ON SOME CENTAUREA L. SPECIES
P138EVALUATION OF IMMUNOMODULATORY EFFECTS OF ACHILLEA WILHELMSII EXTRACT IN FEMALE SWISS ALBINO MICE
P139PHARMACEUTICAL POTENTIAL OF SALVIA PACHYSTACHYS TRAUTV. (LAMIACEAE)
P140DETERMINATION OF IN VITRO CYTOTOXIC ACTIVITY AND CONTENT DETERMINATION WITH HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) OF ACHILLEA MILLEFOLIUM L. EXTRACTS
P141UNVEILING CHEMICAL VARIANCES IN TRIGONELLAE FOENUGRAECI SEMEN FROM 5 BRANDS
P142PHYTOCHEMICAL ANALYSIS AND ANTIBACTERIAL ACTIVITY OF COTA PESTALOZZAE BOISS
P143ISOLATION AND IDENTIFICATION OF SECONDARY METABOLITES FROM TRAGOPOGON COLORATUS C. A. MEY
P144CYTOTOXIC CONSTITUENTS OF LASERPITIUM HISPIDUM M. BIEB AND LASERPITIUM PETROPHILUM BOISS & HOLDR
P145EFFECT OF MELISSA OFFICINALIS ON C. ELEGANS THERMOTOLERANCE
P146CYTOTOXIC ACTIVITY INVESTIGATION OF HERACLEUM SPHONDYLIUM SUBSP. CYLOCARPUM (C. KOCH) DAVIS
P147EVALUATION OF THE COMPLIANCE OF DANDELION SAMPLES SOLD IN HERBALISTS AND ON THE INTERNET ACCORDING TO THE TURKISH PHARMACOPOEIA
P148ENZYM INHIBITORY, ANTIOXIDANT ACTIVITES AND PHYTOCHEMICAL STUDIES ON Stachys cretica L.
P149RESVERATROL AND POLYDATIN CONTENT OF CULTIVATED SIX DIFFERENT PEANUT VARIETIES FROM TÜRKİYE
P150POTENTIAL NEUROPROTECTIVE ACTIVITY OF HALICLONA (RHIZONIERA) SARAI (Pulitzer-Finali, 1969)
P151BIOLOGICAL ACTIVITIES OF VITIS VINIFERA L. (ANTEP KARASI) SEED OIL
P152EFFECT OF NANOTECHNOLOGY-BASED DRUG DEIVERY SYSTEMS ON THE BIOLOGICAL ACTIVITY OF CARVACROL
P153PHYSICIANS’ AWARENESS ON THE SAFETY OF HERBAL PRODUCTS
PHARMACEUTICAL BOTANY
P154EVALUATION OF ANTIOXIDANT AND ANTIMICROBIAL ACTIVITIES OF TEUCRIUM SANDRASICUM AND TEUCRIUM DIVARICATUM SUBSP. GRACEUM
P155HS-SPME/GC/GC-MS ANALYSIS OF VOLATILE CONSTITUENTS OF LEONURUS L.
P156ANTIOXIDANT AND ANTIMICROBIAL ACTIVITIES OF BALLOTA NIGRA L. SUBSP. ANATOLICA DAVIS
P157EXAMINATION OF MORPHOLOGICAL AND ANATOMICAL FEATURES ON 3 GENISTA SPECIES GROWING IN TÜRKİYE
P158APIGENIN AND HOMOGENTISIC ACID PROTECT AGAINST B[a]P INDUCED GENOME DAMAGE IN LUNG CANCER (A549) CELLS
P159ANTICANCER ACTIVITY OF CENTAUREA GLASTIFOLIA L. (ASTERACEAE) LEAF EXTRACT ON A549 CELL LINE
P160CHEMICAL COMPOSITION AND CYTOTOXIC ACTIVITIY OF ENDEMIC ORIGANUM SIPYLEUM L.
P161CHEMICAL COMPOSITION AND ANTIMICROBIAL ACTIVITY OF SIDERITIS LIBANOTICA LABILL. SUBSP. KURDICA (BORNM.) HUB.-MOR.
P162AN ETHNOMEDICINAL STUDY IN ÇANKIRI (TÜRKİYE)
PHARMACOLOGY
P163FERULIC ACID: CANNABINOIDERGIC SYSTEM IS PARTIALLY INVOLVED IN ANALGESIC EFFECT IN INFLAMMATORY PAIN
P164DEXAMETHASONE-MEDIATED REGULATION OF ERAD MECHANISM AND ITS THERAPEUTIC TARGETING IN HEPG2 HEPATOCELLULAR CARCINOMA CELLS
P165CANNABIDIOL NEGATIVELY MODULATES ANDROGENIC SIGNALING IN PROSTATE CANCER CELLS
P166ALTERATIONS IN APOPTOSIS-ASSOCIATED GENE EXPRESSIONS IN LUNG CANCER CELLS IN THE PRESENCE OF IXAZOMIB AND GIVINOSTAT
P167INVESTIGATION OF THE EFFECTS OF PROTOCATECHUIC ACID LOADED NANO-STRUCTURED LIPID CARRIER SYSTEM ON DEPRESSION-LIKE BEHAVIORS IN LPS-INDUCED SYSTEMIC INFLAMMATION IN MICE
P168ANTI-MIGRATION POTENTIAL OF GIVINOSTAT ON HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS
P169THE EFFECT OF KETOGENIC DIET ON ABSENCE SEIZURES IN GENETIC RAT MODEL OF ABSENCE EPILEPSY
P170INVESTIGATION OF THE NEUROPROTECTIVE EFFECT OF METFORMIN AGAINST PENICILLIN-INDUCED NEUROTOXICITY IN SH-SY5Y CELL LINE
P171THE EFFECTS OF XENIN-25 ON INDOMETHACIN-INDUCED GASTRIC ULCERS IN RATS
P172PRECLINICAL EVIDENCE OF COMBINED ACTIVITY OF CURCUMIN AND ROSUVASTATIN: EFFECTS ON HEMATOLOGICAL PARAMETERS IN WISTAR RATS WITH DIET-INDUCED HYPERLIPIDEMIA
P173VORTIOXETINE IMPROVED COGNITIVE SYMPTOMS IN MK-801-INDUCED SCHIZOPHRENIA MODEL OF RATS
CLINICAL PHARMACY
P174EVALUATION OF MEDICATION REGIMEN COMPLEXITY IN ELDERLY PATIENTS WITH CHRONIC KIDNEY DISEASE
P175PROSPECTIVE EVALUATION OF CLINICAL PHARMACY PRACTICES AMONG PATIENTS IN THE HEMATOLOGY BONE MARROW TRANSPLANTATION UNIT
P176POSSIBLE EFFECT OF WILMS TUMOR 1 GENE MUTATION ON TACROLIMUS METABOLISM IN ACUTE MYELOID LEUKEMIA: CASE REPORT
P177MEDICATION REGIMEN COMPLEXITY AND ANTICHOLINERGIC DRUG USE IN OLDER CANCER PATIENTS
P178EVALUATION OF DRUG-RELATED PROBLEMS IN A LIVER TRANSPLANTATION SERVICE
BIOCHEMISTRY
P179THE RADICAL SCAVENGING AND CYCLOOXYGENASES INHIBITORY EFFECTS OF ALCHEMILLA DAGHESTANICA JUZ
P180INVESTIGATION OF THE EFFECT OF ARONIA (ARONIA MELANOCARPA) ON RATS EXPOSED TO RADIATION
P181DETERMINING THE ASSOCIATION BETWEEN HOMOCYSTEINE AND PTX3 LEVELS IN CORONARY ARTERY DISEASE
P182SYNTHESIZING NEW CARBAZOLES VIA DIELS-ALDER REACTION: EVALUATION AS CHEMOTHERAPEUTIC AGENTS FOR BRAIN CANCER
P183CELL VIABILITY AND MIGRATION EFFECTS OF Aurelia aurita JELLYFISH POLAR EXTRACTS ON HUMAN SKIN FIBROBLASTS
P184EFFECTS OF AMITRIPTYLINE ON CELL VIABILITY AND APOPTOSIS IN ACUTE MYELOID LEUKEMIA CELL LINE
P185ICRT14 INDUCES APOPTOSIS THROUGH MLH1 OVEREXPRESSION IN AML CELL LINE
PHARMACEUTICAL TECHNOLOGY
P186PREPARATION OF W/O MICROEMULSION AS A TRANSDERMAL DELIVERY SYSTEM FOR NALTREXONE HYDROCHLORIDE: PHYSICOCHEMICAL CHARACTERIZATION
P1873D-PRINTED STRONTIUM RANELATE LOADED SILK FIBROIN/ALGINATE-BASED SCAFFOLDS FOR ALVEOLAR BONE REGENERATION
P188DESIGN AND EVALUATION OF OPHTHALMIC DELIVERY SYSTEM FORMING IN-SITU GEL CONTAINING BERBERINE
ANALYTICAL CHEMISTRY
P189DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ANALYTICAL METHODS FOR RIBOCICLIB, A DRUG FOR THE TREATMENT OF CERTAIN TYPES OF BREAST CANCER
P190DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ANALYTICAL METHODS FOR INDACATEROL MALEATE
PHARMACOLOGY
P191THE EFFECT OF PROTOCATECHUIC ACID IN CAPSAICIN-INDUCED INFLAMMATORY PAIN AND POSSIBLE MECHANISMS
PHARMACEUTICAL CHEMISTRY
P192SYNTHESIS OF SOME CHROMONE-2-CARBOXAMIDES AND EVALUATION OF THEIR ANTIMICROBIAL ACTIVITIES